CARBETOCIN INJECTION DIN 02489244
Health Canada record
| Active ingredient(s) | CARBETOCIN 100 MCG |
|---|---|
| Dosage form | Solution |
| Route | Intravenous |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | H01BB03 CARBETOCIN |
| Original market date | 21-Jan-2020 |
| Current status date | 08-Jul-2026 |
| Source | Health Canada DPD |
Establishment licence of the holder
Juno Pharma Canada Inc. — licence 3-002916, currently licensed, last inspection rating C (2025-11-24).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing CARBETOCIN
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02496526 | DURATOCIN | FERRING INC | Solution | CARBETOCIN 100 MCG | Marketed |
| 02231593 | DURATOCIN | FERRING INC | Solution | CARBETOCIN 100 MCG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 37858 | 2026-07-08 | Abbreviated New Drug Submission (ANDS) | Administrative: Merger/Buy-out |
| 24217 | 2020-09-14 | Abbreviated New Drug Submission (ANDS) | MANUFACTURER NAME CHANGE |
| 22243 | 2019-06-07 | Abbreviated New Drug Submission (ANDS) |
International API supply for CARBETOCIN
1 active FDA Drug Master Files.
Request a quote for CARBETOCIN INJECTION